TIDES ® 2013 Advisory Board

Oligonucleotide and Peptide Manufacturing, Technology and Product Development

Kathryn L. Ackley, Ph.D., Senior Director Cincinnati Operations, Avecia

Firoz Antia, Ph.D., CMC Team Director, Pharmaceutical Operations and Technology, Biogen Idec

Mimoun Ayoub, Ph.D., Vice President, Global Business, Sales and Strategic Development, Peptisyntha, Member Of The Solvay Group, Belgium

Neil H. Baine, Ph.D., Executive Director, Scinovo, Preclinical Development, GlaxoSmithKline Pharmaceuticals

Doug Brooks, Ph.D., Executive Director, Chemistry, Regado Biosciences

Bob D. Brown, Ph.D., Senior Vice President, Research, Dicerna Pharmaceuticals

Uditha deAlwis, Senior Director, Analytical Sciences, Avecia

Andrew Dibble, Ph.D., Director, Pharmaceutical Development, Isis Pharmaceuticals, Inc.

Alex Fässler, Ph.D., President and COO, Bachem Americas Inc.

Thomas Forman, Advisor Project Management, Project Management, Eli Lilly and Co.

Mark Francis, MRSC, CChem, Csi, Director, Formulation Process and Analysis, UK, GlaxoSmithKline, United Kingdom

Peter Hoffmann, Ph.D.

Christopher P. Holmes, Ph.D., Executive Director, Chemistry, Affymax, Inc.

Troels Koch, Ph.D., Vice President and CTO, Santaris Pharma A/S, Denmark

Rodney Lax, Ph.D., Senior Director, Business Development, PolyPeptide Group (Torrance)

Zhen Li, Ph.D., Director, Chemistry, Merck Research Laboratories

David Litzinger, Ph.D., Director, Formulations Development, Allergan, Inc.

Derek Maclean, Director, Chemistry, Kai Pharmaceuticals

Bing Mao, Ph.D., Associate Director, Process Research, Merck & Co., Inc.

John P. Mayer, Ph.D., Senior Research Advisor, Eli Lilly and Co.

Paul McCormac, Ph.D., Director, Biomanufacturing Sciences Group, Pfizer Global Supply

Michael McGinley, Bioseparations Product Manager, Phenomenex

Paul Metz, Senior Director, Manufacturing Operations, Agilent Technologies, Inc.

Bruce H. Morimoto, Ph.D., Vice President, Drug Development, Allon Therapeutics Inc., Canada

Gary F. Musso, Ph.D., President, Musso and Associates LLC

Lubomir V. Nechev, Ph.D., Vice President, Process Chemistry, Alnylam Pharmaceuticals, Inc.

Rodney Parsons, Ph.D., Group Director, Chemical Development, Bristol-Myers Squibb

El Djouhar Rekai, Ph.D., Upstream Group Leader, Lonza, Belgium

Claus Rentel, Ph.D., Executive Director, Analytical Development Quality Control, Isis Pharmaceuticals

Christopher A. Rhodes, Ph.D., President, Christopher A Rhodes & Associates LLC

G. Susan Srivatsa, Ph.D., President, ElixinPharma

James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, Quark Pharmaceuticals, Inc.

David Tumelty, Ph.D., Associate Director, Chemistry, BioTherapeutics R&D, Pfizer Inc.

Fran Wincott, Ph.D., President, Wincott & Associates, LLC

Oligonucleotide Therapeutics Discovery

David Brown, Ph.D., Director of Discovery, Mirna Therapeutics

Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, Quark Pharmaceuticals, Inc., Israel

Troels Koch, Ph.D., Vice President, Research and Chief Technology Officer, Santaris Pharma, Denmark

Satya Kuchimanchi, Ph.D., Associate Director, RNAi Lead Development, Alnylam Pharmaceuticals, Inc.

Muthiah (Mano) Manoharan, Ph.D., Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals, Inc.

Pamela Pavco, Ph.D., Chief Development Officer, RXi Pharmaceuticals

Dmitry Samarsky, Ph.D., Executive Vice President, Technology Development, Guangzhou RiboBio Co. Ltd, China

Peptide Discovery and Development

Jesse Z. Dong, Ph.D., Vice President, Compound Discovery, IPSEN

Hanjo Hennemann, Ph.D., Chief Scientific Officer, Nexigen GmbH, Germany

Derek Maclean, Ph.D., Director, Process Engineering, Amgen

Tomi K. Sawyer, Ph.D., Chief Scientific Officer and Senior Vice President, Aileron Therapeutics Inc.

Peter Timmerman, Ph.D., Chief Technology Officer, Pepscan Therapeutics, The Netherlands

David Tumelty, Ph.D., Associate Director Chemistry, BioTherapeutics R&D, CovX, Pfizer

Thomas Vorherr, Ph.D., Director, Peptide Discovery, Novartis Pharma AG, Switzerland

Paul Watt, Ph.D., CEO, Phylogica, Ltd, Australia

Nucleic Acids Technologies for Molecular Diagnostics

Thomas Battersby, Ph.D., Senior Manager, Siemens Healthcare Diagnostics

B. Melina Cimler, Ph.D., Vice President, Quality and Regulatory, Illumina, Inc.

Dick Keys, Ph.D., President, Advanced Biotectonics Consulting

Michael McGinley, Bioseparations Product Manager, Phenomenex